Glipizide and Brain natriuretic peptide increased - a phase IV clinical study of FDA data

Summary:

Brain natriuretic peptide increased is reported as a side effect among people who take Glipizide (glipizide), especially for people who are male, 60+ old, also take Digoxin, and have Diabetic retinal oedema.

The phase IV clinical study analyzes which people have Brain natriuretic peptide increased when taking Glipizide. It is created by eHealthMe based on reports of 63,661 people who have side effects when taking Glipizide from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Brain natriuretic peptide increased?

Brain natriuretic peptide increased is found to be associated with 522 drugs and 552 conditions by eHealthMe. Check the latest studies of Brain natriuretic peptide increased.

On Aug, 02, 2026

63,661 people reported to have side effects when taking Glipizide.
Among them, 27 people (0.04%) have Brain natriuretic peptide increased.

Could Glipizide cause Brain natriuretic peptide increased?

Among these 27 people:

What is the gender of people who have Brain natriuretic peptide increased when taking Glipizide? *

female: 40 %
male: 60 %

What is the age of people who have Brain natriuretic peptide increased when taking Glipizide? *

What are other drugs people take besides Glipizide? *

What are other side effects people have besides Brain natriuretic peptide increased? *

Cardiac Failure Congestive: 11 people, 40.74%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 33.33%
Blood Glucose Increased: 8 people, 29.63%
Dyspnea (difficult or laboured breathing): 8 people, 29.63%
Nausea And Vomiting: 7 people, 25.93%
Weakness: 7 people, 25.93%
Blood Urea Increased: 7 people, 25.93%
International Normalised Ratio Increased: 6 people, 22.22%
Oedema Peripheral (superficial swelling): 6 people, 22.22%
Anaemia (lack of blood): 6 people, 22.22%

What are the existing conditions these people have? *

Visual Impairment: 3 people, 11.11%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 11.11%
Osteoporosis (bones weak and more likely to break): 2 people, 7.41%
Multiple Myeloma (cancer of the plasma cells): 2 people, 7.41%
High Blood Pressure: 2 people, 7.41%
Cardiac Failure: 2 people, 7.41%
Non-Hodgkin's Lymphoma Recurrent (reoccurrence malignant (cancer) cells form in the lymph system): 1 person, 3.70%
Interstitial Lung Disease: 1 person, 3.70%
Hepatoblastoma (liver cancer): 1 person, 3.70%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and have Brain natriuretic peptide increased?

- Check whether Brain natriuretic peptide increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glipizide:

Glipizide (64,852 reports)

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Brain natriuretic peptide increased:

Brain natriuretic peptide increased (522 drugs)

Browse all the conditions that are associated with Brain natriuretic peptide increased:

Brain natriuretic peptide increased (552 conditions)

Related publications that referenced our studies

Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on glipizide (the active ingredients of Glipizide) and Glipizide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.